In a population-based, sibling-controlled cohort study Jiangwei Sun and colleagues explore the long-term risk of arrhythmias in patients with inflammatory bowel disease.
<p style="text-align:justify"><strong>(16 October 2023, Copenhagen, Denmark) A groundbreaking new study, presented today at UEG Week 2023, has discovered a significant connection between birthweight and the onset of nonalcoholic fatty liver disease , now known as metabolic dysfunction-associated steatotic liver disease (MASLD), in young people.<sup>1</sup> Most notably, babies with a low birthweight were found to be four times more likely to develop MASLD in childhood, adolescence or young adulthood.<sup>1</sup></strong></p>
In an observational cohort study published in the September 2023 issue of The Lancet, Jiangwei Sun, Ph.D., from the Karolinska Institutet in Stockholm, Sweden, and his colleagues compared statin users with non-statin users to determine the risk of colorectal cancer in patients with IBD.
Patients with nonalcoholic fatty liver disease had a significantly greater risk for severe infection requiring hospitalization vs. the general population, with an absolute risk difference of more than 17%at 20 years after diagnosis.“NAFLD is the most common chronic liver disease, affecting approximately one-quarter of all adults worldwide, but despite its high prevalence, we still have a